{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:54:53Z","timestamp":1781715293156,"version":"3.54.5"},"reference-count":26,"publisher":"Norwegian Medical Association","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.18.0819","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T09:07:39Z","timestamp":1571821659000},"source":"Crossref","is-referenced-by-count":0,"title":["A man in his seventies with back pain, gastrointestinal symptoms and rash"],"prefix":"10.4045","volume":"139","author":[{"given":"Silje","family":"Johansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Helgeland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Vetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingunn","family":"Dybedal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5439-8411","authenticated-orcid":false,"given":"H\u00e5kon","family":"Reikvam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2019,10,21]]},"reference":[{"key":"ref=1","unstructured":"Fantoni\u00a0M, Trecarichi\u00a0EM, Rossi\u00a0B et al. Epidemiological and clinical features of pyogenic spondylodiscitis. Eur Rev Med Pharmacol Sci 2012; 16: 2\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22655478&dopt=Abstract"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Limdi\u00a0JK, Hyde\u00a0GM. Evaluation of abnormal liver function tests. Postgrad Med J 2003; 79: 307\u201312. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12840117&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fpmj.79.932.307","DOI":"10.1136\/pmj.79.932.307"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Flores-Mireles\u00a0AL, Walker\u00a0JN, Caparon\u00a0M et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 2015; 13: 269\u201384. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25853778&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038%2Fnrmicro3432","DOI":"10.1038\/nrmicro3432"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Gowin\u00a0K, Verstovsek\u00a0S, Daver\u00a0N et al. Limitations of fibrosis grade as diagnostic criteria for post polycythemia vera and essential thrombocytosis myelofibrosis. Leuk Res 2015; 39: 684\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25922307&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.leukres.2015.04.004","DOI":"10.1016\/j.leukres.2015.04.004"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Aspestrand\u00a0F, Schrumpf\u00a0E, Jacobsen\u00a0M et al. Increased lymphatic flow from the liver in different intra- and extrahepatic diseases demonstrated by CT. J Comput Assist Tomogr 1991; 15: 550\u20134. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2061465&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097%2F00004728-199107000-00004","DOI":"10.1097\/00004728-199107000-00004"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Scherber\u00a0RM, Borate\u00a0U. How we diagnose and treat systemic mastocytosis in adults. Br J Haematol 2018; 180: 11\u201323. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29048112&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fbjh.14967","DOI":"10.1111\/bjh.14967"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Horny\u00a0HP, Sotlar\u00a0K, Valent\u00a0P et al. Mastocytosis: a disease of the hematopoietic stem cell. Dtsch Arztebl Int 2008; 105: 686\u201392. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19623287&dopt=Abstract","DOI":"10.3238\/arztebl.2008.0686"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Cohen\u00a0SS, Skovbo\u00a0S, Vestergaard\u00a0H et al. Epidemiology of systemic mastocytosis in Denmark. Br J Haematol 2014; 166: 521\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24761987&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fbjh.12916","DOI":"10.1111\/bjh.12916"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Valent\u00a0P. Diagnosis and management of mastocytosis: an emerging challenge in applied hematology. Hematology (Am Soc Hematol Educ Program) 2015; 2015: 98\u2013105. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26637707&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1182%2Fasheducation-2015.1.98","DOI":"10.1182\/asheducation-2015.1.98"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Valent\u00a0P, Akin\u00a0C, Escribano\u00a0L et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37: 435\u201353. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17537151&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fj.1365-2362.2007.01807.x","DOI":"10.1111\/j.1365-2362.2007.01807.x"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Valent\u00a0P, Akin\u00a0C, Metcalfe\u00a0DD. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood 2017; 129: 1420\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28031180&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1182%2Fblood-2016-09-731893","DOI":"10.1182\/blood-2016-09-731893"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Kirshenbaum\u00a0AS, Goff\u00a0JP, Semere\u00a0T et al. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 1999; 94: 2333\u201342. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10498605&dopt=Abstract","DOI":"10.1182\/blood.V94.7.2333.419k30_2333_2342"},{"key":"ref=13","unstructured":"Wang\u00a0SA, Hutchinson\u00a0L, Tang\u00a0G et al. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components. Am J Hematol 2013; 88: 219\u201324. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23440662&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fajh.23380"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Chatterjee\u00a0A, Ghosh\u00a0J, Kapur\u00a0R. Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder. Oncotarget 2015; 6: 18250\u201364. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26158763&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.18632%2Foncotarget.4213","DOI":"10.18632\/oncotarget.4213"},{"key":"ref=15","unstructured":"Robyn\u00a0J, Metcalfe\u00a0DD. Systemic mastocytosis. Adv Immunol 2006; 89: 169\u2013243. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16682275&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS0065-2776(05)89005-4"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Carter\u00a0MC, Metcalfe\u00a0DD, Komarow\u00a0HD. Mastocytosis. Immunol Allergy Clin North Am 2014; 34: 181\u201396. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24262698&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.iac.2013.09.001","DOI":"10.1016\/j.iac.2013.09.001"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Almedal\u00a0H, Vorland\u00a0M, Aarsand\u00a0AK et al. Myeloproliferative neoplasiar og JAK2-mutasjonar. Tidsskr Nor Legeforen 2016; 136: 1889\u201394. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27929554&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.4045%2Ftidsskr.16.0128","DOI":"10.4045\/tidsskr.16.0128"},{"key":"ref=18","unstructured":"Arber\u00a0DA, Orazi\u00a0A, Hasserjian\u00a0R et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127: 2391\u2013405. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27069254&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1182%2Fblood-2016-03-643544"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Pardanani\u00a0A. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management. Am J Hematol 2015; 90: 250\u201362. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25688753&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fajh.23931","DOI":"10.1002\/ajh.23931"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Valent\u00a0P, Akin\u00a0C, Hartmann\u00a0K et al. Advances in the classification and treatment of mastocytosis: Current status and outlook toward the future. Cancer Res 2017; 77: 1261\u201370. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28254862&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1158%2F0008-5472.CAN-16-2234","DOI":"10.1158\/0008-5472.CAN-16-2234"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Broesby-Olsen\u00a0S, Dybedal\u00a0I, G\u00fclen\u00a0T et al. Multidisciplinary management of mastocytosis: Nordic expert group consensus. Acta Derm Venereol 2016; 96: 602\u201312. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26694951&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2340%2F00015555-2325","DOI":"10.2340\/00015555-2325"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Lim\u00a0KH, Pardanani\u00a0A, Butterfield\u00a0JH et al. Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine. Am J Hematol 2009; 84: 790\u20134. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19890907&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fajh.21561","DOI":"10.1002\/ajh.21561"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Gotlib\u00a0J, Kluin-Nelemans\u00a0HC, George\u00a0TI et al. Efficacy and safety of midostaurin in advanced systemic mastocytosis. N Engl J Med 2016; 374: 2530\u201341. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27355533&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056%2FNEJMoa1513098","DOI":"10.1056\/NEJMoa1513098"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Pardanani\u00a0A, Lasho\u00a0T, Elala\u00a0Y et al. Next-generation sequencing in systemic mastocytosis: Derivation of a mutation-augmented clinical prognostic model for survival. Am J Hematol 2016; 91: 888\u201393. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27214377&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fajh.24426","DOI":"10.1002\/ajh.24426"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Naumann\u00a0N, Jawhar\u00a0M, Schwaab\u00a0J et al. Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis. Genes Chromosomes Cancer 2018; 57: 252\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29341334&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fgcc.22526","DOI":"10.1002\/gcc.22526"},{"key":"ref=26","unstructured":"Dalgaard\u00a0J, Ritland\u00a0S, Brinch\u00a0L et al. Mastocytose\u2013en oversikt belyst ved to sykehistorier. Tidsskr Nor L\u00e6geforen 2000; 120: 1312\u20135. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10868093&dopt=Abstract"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["En mann i 70-\u00e5rene med ryggsmerter, mageplager og utslett"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:56:39Z","timestamp":1781711799000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2019\/10\/noe-laere-av\/en-mann-i-70-arene-med-ryggsmerter-mageplager-og-utslett"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,21]]},"references-count":26,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2019,10,22]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.18.0819","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,21]]}}}